CD47 Checkpoint Blockade to treat Choroid Plexus Carcinoma

CPC is a rare tumor, and it is hard to find human CPC cell lines to study the effect of different therapies on killing the tumor. We are in the process of purchasing mouse CPC cell lines from RIKEN Cell Bank, Japan, and we will try our anti-CD47 treatment on mouse cell lines. Still, human-derived CPC cell lines are very critical to test the efficacy of the anti-CD47 treatment in a human setting.